Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1 1

Status

Completed 2Recruiting 1

Sponsor Class

OTHER_GOV 1OTHER 1NIH 1

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 3Other solid neoplasm 3NET 1Endocrine 1

Conditions

Solid Tumors 4Advanced Solid Tumors 4Solid Tumor 3Mesothelioma 3Advanced Solid Tumor 3Advanced Solid Tumours 2Thymoma 1Neuroendocrine Tumors 1Mesothelioma, Malignant 1Malignant Solid Tumors 1Lung Neoplasms 1Advanced Solid Tumor, Adult 1Advanced Cancer 1

Interventions

Pemetrexed 40Cisplatin 35pembrolizumab 21Nivolumab 17Carboplatin 16Ipilimumab 13Gemcitabine 10Cyclophosphamide 9fludarabine 6durvalumab 6Bevacizumab 6Radiotherapy, Intensity-Modulated 4LMB-100 4Drug Therapy 4Dexamethasone 4tremelimumab 3tazemetostat 3spartalizumab 3olaparib 3niraparib 3atezolizumab 3anetumab ravtansine 3amatuximab 3Vinorelbine 3Paclitaxel 3Oxaliplatin 3Imatinib Mesylate 3Fluorouracil 3Cerebral Decortication 3Blood Specimen Collection 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Mesothelioma × olaparib × Other solid neoplasm × Clear all
NCT04375267 2026-04-14

LuPARP

Vastra Gotaland Region

Phase 1 Completed
18 enrolled
EndocrineNETOther solid neoplasmThoracic

Mesothelioma, Thymoma, Neuroendocrine Tumors

NCT04515836 2025-05-06

Olaparib in Patients With HRD Malignant Mesothelioma

University of Chicago

Phase 2 Recruiting
56 enrolled
Other solid neoplasmThoracic

Mesothelioma, Malignant, Lung Neoplasms, Mesothelioma

NCT03531840 2021-04-09

Olaparib in People With Malignant Mesothelioma

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
23 enrolled 16 charts
Other solid neoplasmThoracic

Mesothelioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡